Vaccine Design and Immunoinformatics
Advances in Bioinformatics, Page: 137-149
2021
- 2Citations
- 3Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
The emanation use of vaccines has shown tremendous applications of computational algorithms that can be used for amelioration of health globally. Vaccine Research has become a center area of research that embarks its applications to save several lives, reduced cost of treatment, and potential inhibitor of infectious diseases. The stimulating progress of immunoinformatics approach with the concept of peptide vaccines has proven to be productive way to target unknown antigenic proteins, complex life-cycle of infectious diseases, variability of immune system response, and long term protection. This Chapter reviews the comprehensive database analysis for the construction of vaccine design targeting epitope based approach which has proven to be a very robust method for the characterization of vaccine targets for systemic models of vaccine. The design of vaccine from traditional to computational methods enables to understand the complexity of disease causing organisms and their hyper variable nature. The investigations of vaccine include rigorous methods that validate the designed vaccine to be antigenic, immunogenic, and non-allergenic and higher solubility and furthermore predicted designed vaccine should have the capability to trigger high immune responses. The docking and simulation of the predicted peptides provide insight information of the binding energy and the stability of vaccine candidates for a better accuracy.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85159391543&origin=inward; http://dx.doi.org/10.1007/978-981-33-6191-1_8; https://link.springer.com/10.1007/978-981-33-6191-1_8; https://link.springer.com/content/pdf/10.1007/978-981-33-6191-1_8; https://dx.doi.org/10.1007/978-981-33-6191-1_8; https://link.springer.com/chapter/10.1007/978-981-33-6191-1_8
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know